Breaking News Instant updates and real-time market news.

MENT

Mentor Graphics

$28.81

0.44 (1.55%)

06:20
10/19/16
10/19
06:20
10/19/16
06:20

Mentor Graphics initiated with an Outperform at Credit Suisse

Credit Suisse analyst Farhan Ahmad initiated Mentor Graphics with an Outperform and a $34 price target. The analyst believes the Street is underestimating Mentor's growth and sees potential for multiple expansion as the company starts to deliver. Additionally, Ahmad said Mentor screens well as a potential target for for Systems Design Software companies given the increasing importance of EDA companies in systems design.

MENT Mentor Graphics
$28.81

0.44 (1.55%)

02/22/16
02/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on the today's top five analyst upgrades with this list compiled by The Fly: 1. CSX (CSX) upgraded to Buy from Neutral at BofA/Merrill by analyst Ken Hoexter, who also increased his price target to $28 from $25. He said overall industry volume comps begin to get easier beginning in April and believes CSX's multiple should expand as volume stabilize and coal pressures subside. Hoexter also upgraded Knight Transportation (KNX) and Swift Transport (SWFT) to Buy from Neutral and Werner (WERN) and Genesee & Wyoming (GWR) upgraded to Neutral from Underperform. 2. WellCare (WCG) upgraded to Overweight from Neutral at JPMorgan by analyst Gary Taylor, who raised his price target to $114 from $80. Taylor cited an improved Medicare Advantage outlook following the Centers for Medicare and Medicaid Services' 2017 Advance Notice and said the agency's decision to not explicitly recoup the 2017 HIP Holiday is "quite material" to WellCare. WEllCare was also upgraded to Neutral from Underperform at Bofa/Merrill. 3. Cree (CREE) upgraded to Overweight from Neutral at Piper Jaffray by analyst Mike Ritzenthaler after his firm's channel checks with lighting distributors indicated solid volume growth in the order books for 2016. 4. Mentor Graphics (MENT) upgraded to Buy from Neutral at DA Davidson as it believes that the company's announcement that it will repurchase 8.1M shares from Carl Icahn, along with what the firm sees as stabilizing industry fundamentals, has improved the stock's risk/reward ratio. 5. IMAX (IMAX) upgraded to Outperform from Netural at Wedbush by analyst Michael Pachter. The valuation is favorable while the company is seeing an improving pace of screen installations and an improving premium film slate in 2016, Pachter said. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/16
DADA
08/19/16
DOWNGRADE
DADA
Neutral
Mentor Graphics downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Thomas Diffely downgraded Mentor Graphics to Neutral following solid Q2 results based on share valuation.
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded to Buy from Neutral at DA Davidson
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded on multiple catalysts at DA Davidson
As noted earlier, DA Davidson upgraded Mentor Graphics to Buy from Neutral. Analyst Thomas Diffely says that the company is benefiting from multiple catalysts, including exposure to vertical markets that will enable multi-year growth, solid cash flow, and an activist investor that can help the company unlock value. He thinks that the company can benefit by optimizing its operations, and he finds the stock's valuation attractive. Target to $32 from $24.

TODAY'S FREE FLY STORIES

AAPL

Apple

$136.53

-0.58 (-0.42%)

15:21
02/24/17
02/24
15:21
02/24/17
15:21
Options
Apple expiring ATM straddle is active as shares pin to $136 into the final hour »

Apple expiring ATM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

PPRUY

Kering

$24.38

0.055 (0.23%)

15:19
02/24/17
02/24
15:19
02/24/17
15:19
Conference/Events
Kering management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

$NSD

NASDAQ Market Internals

15:17
02/24/17
02/24
15:17
02/24/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
02/24/17
02/24
15:16
02/24/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$128.69

-1.04 (-0.80%)

15:14
02/24/17
02/24
15:14
02/24/17
15:14
Conference/Events
Aetna management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

WMT

Wal-Mart

$72.37

1.055 (1.48%)

, BBY

Best Buy

$45.75

1.435 (3.24%)

15:12
02/24/17
02/24
15:12
02/24/17
15:12
Periodicals
White House denying Cohn comments on border-adjustment tax, Axios says »

The White House has…

WMT

Wal-Mart

$72.37

1.055 (1.48%)

BBY

Best Buy

$45.75

1.435 (3.24%)

COST

Costco

$175.85

-0.66 (-0.37%)

TGT

Target

$66.59

1.61 (2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 14

    Mar

  • 19

    Mar

  • 28

    Mar

PYPL

PayPal

$42.53

0.11 (0.26%)

15:11
02/24/17
02/24
15:11
02/24/17
15:11
Options
$1M premium seller in Paypal »

$1M premium seller in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

WSTC

West Corp.

$24.66

-0.09 (-0.36%)

15:09
02/24/17
02/24
15:09
02/24/17
15:09
Conference/Events
West Corp. to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FCNCA

First Citizens

$363.85

0.03 (0.01%)

15:07
02/24/17
02/24
15:07
02/24/17
15:07
Hot Stocks
Breaking Hot Stocks news story on First Citizens »

Vanguard reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTR

Dollar Tree

$77.57

-0.97 (-1.24%)

15:06
02/24/17
02/24
15:06
02/24/17
15:06
Options
Dollar Tree call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ADRO

Aduro Biotech

$11.15

-0.25 (-2.19%)

15:01
02/24/17
02/24
15:01
02/24/17
15:01
Hot Stocks
Meet Aduro: CEO Isaacs says partnerships help development efforts »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRA

Sierra Oncology

$1.42

-0.05 (-3.40%)

15:01
02/24/17
02/24
15:01
02/24/17
15:01
Hot Stocks
Breaking Hot Stocks news story on Sierra Oncology »

Frazier Healthcare VI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGI

Endurance

$9.00

-0.3 (-3.23%)

14:59
02/24/17
02/24
14:59
02/24/17
14:59
Rumors
Rumor moving shares of Endurance »

Rumor: Endurance late day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

WSTC

West Corp.

$24.66

-0.09 (-0.36%)

14:57
02/24/17
02/24
14:57
02/24/17
14:57
Periodicals
West Corp. buyout looks challenging, Dealreporter says »

Private equity firms have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LUK

Leucadia

$25.63

-0.09 (-0.35%)

14:50
02/24/17
02/24
14:50
02/24/17
14:50
Options
Leucadia options imply 2.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWJ

iShares MSCI Japan Index Fund

$51.43

-0.205 (-0.40%)

14:41
02/24/17
02/24
14:41
02/24/17
14:41
Options
iShares Japan Fund draws a notable option block »

iShares Japan Fund draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RP

RealPage

$33.70

-0.5 (-1.46%)

14:36
02/24/17
02/24
14:36
02/24/17
14:36
Conference/Events
RealPage management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 02

    Mar

VLKAY

Volkswagen

$30.91

0.135 (0.44%)

14:29
02/24/17
02/24
14:29
02/24/17
14:29
Hot Stocks
Volkswagen took EUR6.4B in charges from diesel scandal in FY16 »

Volkswagen said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRO

Aduro Biotech

$11.15

-0.25 (-2.19%)

, NVS

Novartis

$77.15

-0.2959 (-0.38%)

14:27
02/24/17
02/24
14:27
02/24/17
14:27
Hot Stocks
Meet Aduro: Progress across 3 main platforms seen in 2017 »

In an exclusive interview…

ADRO

Aduro Biotech

$11.15

-0.25 (-2.19%)

NVS

Novartis

$77.15

-0.2959 (-0.38%)

JNJ

Johnson & Johnson

$122.09

1.19 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 27

    Mar

  • 26

    Jun

SU

Suncor

$31.55

-1.12 (-3.43%)

14:26
02/24/17
02/24
14:26
02/24/17
14:26
Options
Suncor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$30.91

0.135 (0.44%)

14:21
02/24/17
02/24
14:21
02/24/17
14:21
Hot Stocks
Volkswagen sees FY17 operating return on sales 6%-7% »

The Volkswagen Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPKE

Spark Energy

$25.55

0.35 (1.39%)

14:21
02/24/17
02/24
14:21
02/24/17
14:21
Periodicals
Spark Energy hires Morgan Stanley to advise on potential sale, SparkSpread says »

Spark Energy has retained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

VLKAY

Volkswagen

$30.91

0.135 (0.44%)

14:21
02/24/17
02/24
14:21
02/24/17
14:21
Earnings
Volkswagen reports FY16 EPS EUR10.24 vs (EUR3.20) last year »

Reports FY16 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPKE

Spark Energy

$25.55

0.35 (1.39%)

14:19
02/24/17
02/24
14:19
02/24/17
14:19
Periodicals
Breaking Periodicals news story on Spark Energy »

Spark Energy put up for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

SPKE

Spark Energy

$25.55

0.35 (1.39%)

14:18
02/24/17
02/24
14:18
02/24/17
14:18
Hot Stocks
Breaking Hot Stocks news story on Spark Energy »

Spark Energy jumps 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.